abstract |
The present invention relates to compounds, pharmaceutical compositions and methods for regulating the function of estrogen receptor hER-α36, for preventing and/or treating diseases mediated by estrogen receptor hER-α36, preventing and/or treating bone Loosening, inducing cell death and/or inhibiting cell proliferation, and preventing and/or treating diseases related to abnormal proliferation of cells such as cancer. |